• What is Impurity Profiling & Characterization?

    Impurity profiling and characterization involve identifying, quantifying, and studying impurities that may form during pharmaceutical development, manufacturing, storage, or degradation processes.

  • Why is it Important?

    Accurate impurity analysis helps improve product safety, strengthen quality control, support stability studies, and ensure compliance with global pharmaceutical regulations. In addition, it reduces regulatory risks and improves product consistency.

  • How We Support Your Success

    Our experts combine advanced analytical techniques, scientific expertise, and regulatory understanding to deliver reliable impurity analysis and characterization strategies tailored to your product requirements.

Our Scientific Analytical Approach

At Indivirtus, we begin by reviewing the product composition, manufacturing process, degradation behavior, and analytical requirements to design the right impurity assessment strategy. We evaluate potential process impurities, degradation products, and solvent residues using validated analytical methods and advanced instrumentation.

Next, we perform impurity profiling, residual solvent analysis, unknown impurity identification, and degradation pathway characterization to improve product understanding and support regulatory compliance. Our approach helps strengthen quality control, improve product stability assessment, and support successful pharmaceutical submissions.

Impurity Analysis Deliverables

  • Related Substance Analysis: Detailed impurity profiling studies designed to identify and quantify process-related impurities, degradation products, and related compounds in pharmaceutical products.

  • Residual Solvent Testing: Accurate solvent residue analysis performed according to global regulatory limits and pharmaceutical safety standards.

  • Unknown Impurity Identification: Advanced analytical investigation and characterization of unidentified peaks, trace compounds, and unexpected degradation products using scientific interpretation and analytical techniques.

  • Degradation Impurity Characterization: Comprehensive analysis of degradation pathways and impurity formation behavior under different stress and storage conditions.

  • Impurity Risk Assessment Support: Scientific evaluation of impurity trends, safety considerations, and quality risks to support long-term product stability and compliance.

  • Regulatory-Ready Impurity Documentation: Structured analytical reports and impurity data packages prepared to support CTD/eCTD submissions and regulatory reviews.

Regulatory Standards & Quality Compliance

Our impurity profiling and characterization services align with internationally accepted pharmaceutical impurity guidelines to ensure accurate analysis, reproducible results, and regulator-ready impurity documentation throughout every stage of product development.

  • ICH Q3A Guidelines: Regulatory standards for impurities in new drug substances and impurity qualification requirements.
  • ICH Q3B Guidelines: Guidance for impurity assessment and control in finished pharmaceutical drug products.
  • ICH Q3C Residual Solvent Guidelines: International standards for evaluating and controlling residual solvent levels in pharmaceutical products.
  • ICH Q2(R2) Analytical Validation: Analytical method validation requirements for reliable impurity testing and quantification.
  • US FDA Impurity Guidance: Regulatory expectations for impurity profiling, degradation studies, and product quality assessment.

Applications & Industry Use Cases

Our impurity profiling and characterization services support pharmaceutical development, stability programs, formulation optimization, manufacturing troubleshooting, quality control investigations, and global regulatory submissions. These services are especially valuable for new chemical entities, generic formulations, complex drug products, and lifecycle management projects.

Why Choose Indivirtus for Impurity Analysis?

Indivirtus combines analytical expertise, scientific precision, and pharmaceutical industry experience to deliver reliable impurity profiling and characterization solutions. Our team focuses on improving product understanding, strengthening quality control, and supporting compliant pharmaceutical development through accurate impurity assessment.

With advanced analytical capabilities, strong regulatory knowledge, and a commitment to scientific excellence, we help pharmaceutical companies reduce impurity-related risks, improve product quality, and accelerate regulatory approval readiness.

Frequently Asked Questions

Frequently Asked Questions

What is impurity profiling in pharmaceutical development? +

Impurity profiling involves identifying, quantifying, and characterizing impurities that may form during pharmaceutical development, manufacturing, storage, or product degradation.

Why is residual solvent testing important? +

Residual solvent testing helps ensure that solvent levels remain within acceptable safety limits, supporting product quality, patient safety, and regulatory compliance.

How are unknown impurities identified? +

Unknown impurities are identified using advanced analytical techniques, scientific interpretation, and characterization studies that help determine impurity structure and origin.

What is degradation impurity characterization? +

Degradation impurity characterization evaluates impurities formed during product degradation under stress or storage conditions to support stability assessment and quality control.

Which industries benefit from impurity profiling services? +

Pharmaceutical companies, biotechnology firms, generic drug manufacturers, CROs, and quality control laboratories benefit from impurity profiling services that support product quality and regulatory compliance.